- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
KURN
EBS
Week ended 31 Jul 2026
Weekly Investor Report
Kuros Biosciences AG · Healthcare · Medical Devices
Latest close
22.86 CHF
15.5%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -0.5% below the Trend Line and sits at 30.0% of its 52-week range. The latest completed week returned 15.5%, after a 19.6% four-week move. The latest news-sentiment score is 57/100.
Setup score
43
out of 100
Latest Close
22.86 CHF
31 Jul 2026
1W Return
15.5%
latest completed week
4W Return
19.6%
short-term follow-through
12W Return
13.6%
quarterly tape
Trend Breadth
38.5%
20 of 52 weeks active
Volume Ratio
2.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
15.5%
Latest completed week; four-week move 19.6%.
Indicator stack
21/68
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
57/100
9 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -0.5% below the Trend Line and sits at 30.0% of its 52-week range. The latest completed week returned 15.5%, after a 19.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1312-week average 0.05
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.13Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 19.6% over four weeks, 13.6% over 12 weeks, and -23.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year20
Trend breadth38.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.40Latest activity-pressure read.
Pressure change133.9%Four-week change in activity pressure.
Leadership-16.85Latest relative-leadership reading.
RS change49.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment57/100
Weighted news tone is neutral across 9 relevant articles.
3 positive · 6 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-33.2%Distance below the 52-week high.
13-week volatility6.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher11 of 2615 weeks finished lower.
Best week+15.5%Week of 31 Jul.
Worst week-11.6%Week of 24 Apr.
Latest week+15.5%Week of 31 Jul.
Shape of recent returns
Strong gains6
Modest gains5
Flat weeks0
Modest losses8
Sharp losses7
Recent vol6.6%13-week weekly-return volatility.
Base vol7.5%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew6.2% / -5.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCH Healthcare
4-week rank1 / 40
Group average-1.1%
Trend breadth47.5%
Trend47.5%active weekly trend signals
MD62.5%positive activity pressure
RS42.5%positive relative leadership
Four-week leaders
IndustryCH Medical Devices
4-week rank1 / 5
Group average7.0%
Trend breadth20.0%
Trend20.0%active weekly trend signals
MD80.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape34/100
Trend, activity pressure, participation, and risk combine to a 34/100 tape read.
Indicator analysis13/100Latest 12-week confirmation: trend 0/12, activity pressure 1/12, relative leadership 0/12.
Activity pressure 0.13; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment57/100Weighted news tone is neutral across 9 relevant articles.
Kuros stock surges after Berenberg initiates with buy rating By Investing.com Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 22.86 CHF | 15.5% | 22.97 CHF | 17.69 CHF | 0.40 | -16.85 | 1.3M | Off |
| 24 Jul 2026 | 19.80 CHF | -4.5% | 23.13 CHF | 17.56 CHF | -0.11 | -28.56 | 681.7K | Off |
| 17 Jul 2026 | 20.74 CHF | -3.3% | 23.39 CHF | 17.45 CHF | -0.42 | -26.03 | 449.9K | Off |
| 10 Jul 2026 | 21.44 CHF | 12.1% | 23.61 CHF | 17.33 CHF | -0.75 | -23.65 | 1.1M | Off |
| 3 Jul 2026 | 19.12 CHF | 4.6% | 23.85 CHF | 17.20 CHF | -1.19 | -33.37 | 637.4K | Off |
| 26 Jun 2026 | 18.28 CHF | -1.2% | 24.23 CHF | 17.09 CHF | -1.34 | -35.80 | 72.1K | Off |
| 19 Jun 2026 | 18.50 CHF | -9.8% | 24.69 CHF | 16.98 CHF | -1.29 | -33.82 | 233.4K | Off |
| 12 Jun 2026 | 20.50 CHF | -0.6% | 24.96 CHF | 16.87 CHF | -1.15 | -26.87 | 107.4K | Off |
| 5 Jun 2026 | 20.62 CHF | -3.4% | 25.19 CHF | 16.75 CHF | -1.09 | -25.13 | 261.1K | Off |
| 29 May 2026 | 21.34 CHF | -1.9% | 25.42 CHF | 16.62 CHF | -1.00 | -23.73 | 604.4K | Off |
| 22 May 2026 | 21.76 CHF | 5.9% | 25.70 CHF | 16.49 CHF | -1.04 | -22.41 | 908.9K | Off |
| 15 May 2026 | 20.54 CHF | 2.1% | 25.97 CHF | 16.36 CHF | -1.15 | -25.46 | 1.0M | Off |
| 8 May 2026 | 20.12 CHF | -0.8% | 26.40 CHF | 16.24 CHF | -0.99 | -26.57 | 1.3M | Off |
| 1 May 2026 | 20.28 CHF | -8.0% | 26.70 CHF | 16.12 CHF | -1.01 | -26.50 | 856.1K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.